ATHA

Athira Pharma, Inc. (ATHA) Porter's 5 Forces Analysis (2026)

Invetso Score: 5.3/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Competitive Rivalry

Score: 5.4 (Moderate)

ATHA operates in a fragmented, project-driven market where peers compete on price and delivery terms, limiting sustained margin expansion.

Global incumbents and regional specialists offer overlapping services, so differentiation is modest and contract wins often depend on bid economics.

Industry demand is cyclical and tied to capital spending, which intensifies rivalry during downcycles and compresses peer pricing discipline.

Threat Of New Entrants

Score:

Capital requirements and technical know-how create some entry friction, but they are not high enough to prevent niche entrants from targeting profitable segments.

Customers can multi-source across qualified vendors, so new competitors can gain share without needing broad scale comparable to global peers.

Regulatory, certification, and relationship hurdles slow entry, yet they mainly delay rather than eliminate competitive pressure on established players.

Bargaining Power Of Suppliers

Score:

ATHA depends on specialized inputs and subcontracted services, which can raise costs when supply tightens and reduce peer-level gross margin stability.

Where critical components are concentrated among a few vendors, suppliers can pass through inflation faster than ATHA can reprice contracts.

Compared with larger global peers, ATHA likely has less procurement scale, making it more exposed to unfavorable terms in constrained markets.

Bargaining Power Of Buyers

Score:

Customers are typically sophisticated and price-sensitive, so ATHA faces pressure to match peer pricing and accept narrower contract economics.

Large buyers can split volumes across vendors, limiting ATHA's ability to defend pricing when competitors bid aggressively.

Long sales cycles and tender-based procurement shift negotiating leverage toward buyers, especially in commoditized or repeatable service lines.

Threat Of Substitutes

Score:

Substitution risk is moderate because customers can often defer projects, redesign specifications, or choose lower-cost alternatives when economics weaken.

Adjacent technologies and alternative service models can cap pricing upside versus peers in more differentiated niches.

However, where ATHA's offerings are tied to compliance or mission-critical requirements, substitutes are less binding than in purely discretionary categories.

Overall Score

Score:

ATHA appears to face a structurally competitive industry with meaningful buyer discipline, moderate supplier pressure, and limited insulation from rivalry, leaving pricing power and margins below stronger global peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Athira Pharma, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →